NASDAQ · NATR
Nature's Sunshine Products, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for NATR: Nov 04, 2026
Nature's Sunshine Products, Inc. Common Stock is expected to report earnings on 11/04/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. The reported EPS for the same quarter last year was $0.36.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
MarketBeat · The Motley Fool · Fintel · Quiver Quantitative- MarketBeat · Aug 15, 12:01 PM EDTNature’s Sunshine Targets $1B Sales, 15% EBITDA Margin in Growth PushNature's Sunshine Products (NASDAQ:NATR) outlined a strategy to double sales to $1 billion and expand EBITDA margins to 15%, with Chief Executive Officer Ken Romanzi pointing to geographic expansion, digital and retail channel development, marketing initiatives and acquisitions a
- The Motley Fool · Aug 14, 11:50 AM EDTNature's Sunshine (NATR) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 7, 1:04 AM EDTNature's Sunshine Products Q2 Earnings Call HighlightsNature's Sunshine Products (NASDAQ:NATR) reported second-quarter net sales of $117 million, its strongest second quarter in company history, as digital growth in North America and continued momentum across much of Asia-Pacific and Europe supported results. Sales increased 2% fro
- MarketBeat · May 8, 5:09 AM EDTNature's Sunshine Products Q1 Earnings Call HighlightsNature's Sunshine Products (NASDAQ:NATR) reported what management called a “very strong” start to 2026, highlighting first-quarter sales growth of 9% and adjusted EBITDA growth of 33% as the company continued to push deeper into digital channels and subscription programs while ex
- The Motley Fool · May 7, 7:08 PM EDTNATR Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Fintel · Mar 26, 10:33 PM EDTNature's Sunshine Products (NATR) Price Target Increased by 46.67% to 33.66The average one-year price target for Nature's Sunshine Products (NasdaqCM:NATR) has been revised to $33.66 / share. This is an increase of 46.67% from the prior estimate of $22.95 dated February 21, 2026. The price target is an average of many targets provide
- The Motley Fool · Mar 12, 10:52 AM EDTNature's Sunshine (NATR) Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Fintel · Nov 11, 7:03 AM ESTDA Davidson Maintains Nature's Sunshine Products (NATR) Buy RecommendationFintel reports that on November 10, 2025, DA Davidson maintained coverage of Nature's Sunshine Products (NasdaqCM:NATR) with a Buy recommendation. Analyst Price Forecast Suggests 10.87% Upside
- The Motley Fool · Aug 1, 2:23 PM EDTNature's Sunshine (NATR) Q2 EPS Up 400%Non-GAAP earnings per share surged to $0.35, beating expectations (GAAP) and Non-GAAP earnings per share surged to $0.35, beating expectations and rising 400.0% compared to Q2 2024.
- Quiver Quantitative · Jul 17, 4:15 PM EDTNature’s Sunshine Products, Inc. to Host Conference Call on Second Quarter Financial Results, Scheduled for July 31, 2025Nature’s Sunshine Products will hold a conference call on July 31, 2025, to discuss Q2 financial results.
- Quiver Quantitative · Jun 25, 4:13 PM EDTNature's Sunshine Products Announces Secondary Public Offering of Common Stock by Fosun Pharma USA, Inc.Nature’s Sunshine announces a secondary stock offering of 2,854,607 shares, solely benefiting Fosun Pharma USA, Inc.
- RTTNews · Jun 2, 9:48 AM EDTNature's Sunshine CEO Terrence Moorehead To Step Down, Backs Annual Outlook; Stock Down(RTTNews) – Nature's Sunshine Products, Inc. (NATR), a maker of herbal and nutritional supplements, said on Monday that its Chief Executive Officer, Terrence Moorehead, has decided to step down, effective upon the appointment of a successor.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Nature's Sunshine Products, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.